Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations, Basis of Presentation and Liquidity (Details)

v3.4.0.3
Nature of Operations, Basis of Presentation and Liquidity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 17, 2015
Jan. 31, 2014
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Nature of Operations and Basis of Presentation (Textual)            
Cash to meet current obligations     $ 5,217 $ 590 $ 1,567 $ 879
Working capital     5,685      
Current assets     7,013     3,275
Current liabilities     1,328     1,720
Net loss     (1,220) (1,529)    
Net cash used in operating activities     (703) $ (977)    
Accumulated deficit     $ (24,665)     (23,445)
Term loan         $ 100
Aggregate common shares   47,351     631,346  
Common stock, par value     $ 0.001     $ 0.001
Convertible note $ 575   $ 575     $ 575
Securities Purchase Agreement [Member] | RENS Technology Inc [Member]            
Nature of Operations and Basis of Presentation (Textual)            
Aggregate common shares 3,537,037          
Common stock, par value $ 0.001          
Aggregate purchase of warrants to common stock 884,259          
Convertible note $ 575          
Securities Purchase Agreement [Member] | RENS Technology Inc [Member] | First Tranche [Member]            
Nature of Operations and Basis of Presentation (Textual)            
Purchaser acquired, shares     1,500,000      
Warrants acquired     375,000      
Purchaser acquired, value     $ 5,250      
Securities close date, description    
In the first tranche, which closed on March 3, 2016.
     
Excercise price of warrants     $ 7.00      
Securities Purchase Agreement [Member] | RENS Technology Inc [Member] | Second tranche [Member]            
Nature of Operations and Basis of Presentation (Textual)            
Purchaser acquired, shares     925,926      
Warrants acquired     231,481      
Purchaser acquired, value     $ 5,000      
Securities close date, description    
In the second tranche, which we except will close by September 2016
     
Excercise price of warrants     $ 10.80      
Securities Purchase Agreement [Member] | RENS Technology Inc [Member] | Third tranche [Member]            
Nature of Operations and Basis of Presentation (Textual)            
Purchaser acquired, shares     1,111,111      
Warrants acquired     277,778      
Purchaser acquired, value     $ 10,000      
Securities close date, description    
In the third tranche, which will close within eighteen months of the closing of the second tranche.
     
Excercise price of warrants     $ 18.00      
Purchaser right description     To provide the Purchaser with a right to participate in 50% (or 100% if shares are to be issued for less than $3.50 per share.      
Cenegenics [Member]            
Nature of Operations and Basis of Presentation (Textual)            
Settlement agreement, Terms     On November 28, 2014, we entered into a settlement agreement with Cenegenics wherein we agreed to accept $1,900 by April 2016, (i.e., $300 in the fourth quarter of 2014 and $100 per month from January 2015 through April 2016) in full satisfaction of Cenegenics's outstanding obligations with respect to units of product produced by the Company, including units that had not yet been shipped to Cenegenics at the time of the settlement agreement.